Skip to main content

Advertisement

SpringerLink
Log in

Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Papanicolaou GA, Silveira FP, Langston AA et al (2019) Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, phase 2 study. Clin Infect Dis 68:1255–1264

    Article  CAS  PubMed  Google Scholar 

  2. Maertens J, Cordonnier C, Jaksch P et al (2019) Maribavir for preemptive treatment of cytomegalovirus reactivation. N Engl J Med 381:1136–1147

    Article  CAS  PubMed  Google Scholar 

  3. Avery RK, Alain S, Alexander BD et al (2022) Maribavir for refractory cytomegalovirus infections with or without resistance post-transplant: results from a phase 3 randomized clinical trial. Clin Infect Dis 75:690–701

    Article  PubMed  Google Scholar 

  4. Chemaly RF, Ullmann AJ, Stoelben S et al (2014) Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation. N Engl J Med 370:1781–1789

    Article  CAS  PubMed  Google Scholar 

  5. Marty FM, Ljungman P, Chemaly RF et al (2017) Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation. N Engl J Med 377:2433–2444

    Article  CAS  PubMed  Google Scholar 

  6. Marty FM, Ljungman PT, Chemaly RF et al (2020) Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation. Am J Transplant 20:1703–1711

    Article  CAS  PubMed  Google Scholar 

  7. Ljungman P, Schmitt M, Marty FM et al (2020) A mortality analysis of letermovir prophylaxis for cytomegalovirus (CMV) in CMV-seropositive recipients of allogeneic hematopoietic cell transplantation. Clin Infect Dis 70:1525–1533

    Article  CAS  PubMed  Google Scholar 

  8. Chou S, Wu J, Song K et al (2019) Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection. Antiviral Res 172:104616

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Chou S, Song K, Wu J, Bo T, Crumpacker C (2022) Drug resistance mutations and associated phenotypes detected in clinical trials of maribavir for treatment of cytomegalovirus infection. J Infect Dis 226(4):576–584

    Article  CAS  PubMed  Google Scholar 

  10. Schubert A, Ehlert K, Schuler-Luettmann S, Gentner E, Mertens T, Michel D (2013) Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient. BMC Infect Dis 13:330

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Jackson Health System, Miami Transplant Institute, Miami, FL, USA

    Julia Bini Viotti & Fabian Dammann

  2. Division of Infectious Disease, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA

    Julia Bini Viotti, Fabian Dammann, Michele I. Morris, Jose F. Camargo & Mohammed Raja

  3. Division of Transplantation and Cellular Therapy, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA

    Antonio Martin Jimenez Jimenez

  4. Department of Pharmacy Services, University of Miami Miller School of Medicine, Miami, FL, USA

    Anthony D. Anderson

Authors
  1. Julia Bini Viotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fabian Dammann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Martin Jimenez Jimenez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anthony D. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michele I. Morris
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jose F. Camargo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mohammed Raja
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammed Raja.

Ethics declarations

Ethical approval

This article does not contain any studies of human participants or animals performed by any of the authors.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bini Viotti, J., Dammann, F., Jimenez Jimenez, A.M. et al. Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient. Ann Hematol 102, 2283–2284 (2023). https://doi.org/10.1007/s00277-023-05265-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-023-05265-8

Search

Navigation